Structure-Activity Relationship of Hetarylpropylguanidines Aiming at the Development of Selective Histamine Receptor Ligands
computational chemistry
histamine H1-4 receptor
ligand design
organ pharmacology
receptor subtype selectivity
Journal
ChemistryOpen
ISSN: 2191-1363
Titre abrégé: ChemistryOpen
Pays: Germany
ID NLM: 101594811
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
10
01
2019
revised:
08
02
2019
entrez:
20
3
2019
pubmed:
20
3
2019
medline:
20
3
2019
Statut:
epublish
Résumé
New classes of alkylated hetarylpropylguanidines with different functionality and variation in spacer length were synthesized to determine their behavior at the four histamine receptor (H
Identifiants
pubmed: 30886786
doi: 10.1002/open.201900011
pii: OPEN201900011
pmc: PMC6401531
doi:
Types de publication
Journal Article
Langues
eng
Pagination
285-297Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Med Chem. 2003 Sep 11;46(19):3957-60
pubmed: 12954048
Nature. 1978 Nov 23;276(5686):403-5
pubmed: 714166
Transl Psychiatry. 2017 Jan 24;7(1):e1013
pubmed: 28117842
Mol Pharmacol. 2001 Mar;59(3):434-41
pubmed: 11179436
Pharmacol Rev. 1997 Sep;49(3):253-78
pubmed: 9311023
Agents Actions. 1975 Dec;5(5):464
pubmed: 1220549
ChemMedChem. 2009 Feb;4(2):232-40
pubmed: 19072936
Drug Discov Today. 2009 May;14(9-10):509-15
pubmed: 19429511
Br J Pharmacol. 2009 May;157(1):24-33
pubmed: 19309354
J Immunol. 2006 Jun 1;176(11):7062-70
pubmed: 16709868
Br J Pharmacol Chemother. 1966 Aug;27(2):427-39
pubmed: 4381779
ACS Omega. 2018 Mar 31;3(3):2865-2882
pubmed: 30221224
Nat Rev Drug Discov. 2008 Apr;7(4):339-57
pubmed: 18382464
Nature. 2011 Jun 22;475(7354):65-70
pubmed: 21697825
Br J Pharmacol. 1975 Mar;53(3):435P-436P
pubmed: 236798
J Med Chem. 2010 Apr 8;53(7):2719-40
pubmed: 20131845
J Pharmacol Exp Ther. 2003 Jun;305(3):1212-21
pubmed: 12626656
Trends Pharmacol Sci. 2011 Apr;32(4):250-7
pubmed: 21414671
J Med Chem. 2009 Oct 22;52(20):6297-313
pubmed: 19791743
Bioorg Med Chem. 2015 Jul 15;23(14):3957-69
pubmed: 25639885
Eur J Med Chem. 2000 Jan;35(1):5-20
pubmed: 10733599
J Med Chem. 1992 Aug 21;35(17):3239-46
pubmed: 1507209
J Med Chem. 2015 Feb 12;58(3):1205-14
pubmed: 25559643
Br J Pharmacol Chemother. 1955 Sep;10(3):270-8
pubmed: 13269701
Am J Physiol. 1979 Nov;237(5):E444-50
pubmed: 91322
J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21
pubmed: 15947036
Mol Pharmacol. 1979 Sep;16(2):417-28
pubmed: 42012
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Feb 6;73:36-40
pubmed: 27773554
Nature. 1972 Apr 21;236(5347):385-90
pubmed: 4401751
Mol Pharmacol. 1999 Jun;55(6):1101-7
pubmed: 10347254
J Biol Chem. 2000 Nov 24;275(47):36781-6
pubmed: 10973974
J Med Chem. 1985 Oct;28(10):1414-22
pubmed: 2931524
Mol Pharmacol. 2001 Mar;59(3):415-9
pubmed: 11179433
J Med Chem. 2009 Apr 23;52(8):2623-7
pubmed: 19317445
Pharmacol Ther. 1995 Jun;66(3):413-63
pubmed: 7494855
J Pharmacol Exp Ther. 2001 Mar;296(3):1058-66
pubmed: 11181941
Br J Pharmacol. 2009 May;157(1):14-23
pubmed: 19413568
ACS Cent Sci. 2017 Mar 22;3(3):143-147
pubmed: 28386587
Physiol Behav. 2016 Oct 15;165:383-91
pubmed: 27568232
Nat Rev Drug Discov. 2008 Jan;7(1):41-53
pubmed: 18172439
Pharmacology. 2002 Nov;66(3):128-35
pubmed: 12372902
Bioorg Med Chem Lett. 2005 Jul 15;15(14):3446-9
pubmed: 15951170
Br J Pharmacol. 2002 Jan;135(2):383-92
pubmed: 11815373
Bioorg Med Chem. 2006 Oct 1;14(19):6570-80
pubmed: 16797997
J Med Chem. 2008 Nov 27;51(22):7193-204
pubmed: 18950149
Pharmacol Rev. 1990 Mar;42(1):45-83
pubmed: 2164693
Nature. 1983 Apr 28;302(5911):832-7
pubmed: 6188956
J Med Chem. 1989 Aug;32(8):1963-70
pubmed: 2569042
Behav Brain Res. 2016 Oct 1;312:415-30
pubmed: 27363923
Mol Pharmacol. 2001 Mar;59(3):420-6
pubmed: 11179434
J Med Chem. 2017 Apr 27;60(8):3314-3334
pubmed: 28388054
ChemMedChem. 2011 Sep 5;6(9):1727-38
pubmed: 21692185
J Med Chem. 2012 Feb 9;55(3):1147-60
pubmed: 22216892
ChemistryOpen. 2019 Mar 05;8(3):285-297
pubmed: 30886786